Pages that link to "Q61554599"
Jump to navigation
Jump to search
The following pages link to Molecular Characterization of Five Neutralizing Anti-HIV Type 1 Antibodies: Identification of Nonconventional D Segments in the Human Monoclonal Antibodies 2G12 and 2F5 (Q61554599):
Displaying 50 items.
- Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies (Q24561905) (← links)
- Ig Constant Region Effects on Variable Region Structure and Function (Q26766449) (← links)
- Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein (Q28140278) (← links)
- A human antibody to the CD4 binding site of gp120 capable of highly potent but sporadic cross clade neutralization of primary HIV-1. (Q31132248) (← links)
- Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals (Q33526340) (← links)
- Comparison of Antibody Repertoires Produced by HIV-1 Infection, Other Chronic and Acute Infections, and Systemic Autoimmune Disease (Q33867353) (← links)
- Inhibition of in vivo HIV infection in humanized mice by gene therapy of human hematopoietic stem cells with a lentiviral vector encoding a broadly neutralizing anti-HIV antibody (Q33990484) (← links)
- 3D6 and 4B3: Recombinant expression of two anti-gp41 antibodies as dimeric and secretory IgA. (Q34175588) (← links)
- Very few substitutions in a germ line antibody are required to initiate significant domain exchange. (Q34178341) (← links)
- Evaluation of the potency of the anti-idiotypic antibody Ab2/3H6 mimicking gp41 as an HIV-1 vaccine in a rabbit prime/boost study (Q34312108) (← links)
- The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. (Q34342352) (← links)
- Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope (Q34348303) (← links)
- Thermodynamic analysis of the binding of 2F5 (Fab and immunoglobulin G forms) to its gp41 epitope reveals a strong influence of the immunoglobulin Fc region on affinity (Q34389587) (← links)
- Effect of epitope position on neutralization by anti-human immunodeficiency virus monoclonal antibody 2F5 (Q34434753) (← links)
- MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1. (Q34681455) (← links)
- Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12. (Q34781840) (← links)
- IgM Repertoire Biodiversity is Reduced in HIV-1 Infection and Systemic Lupus Erythematosus (Q35057901) (← links)
- Crystal structure of the HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomannose (Q35119778) (← links)
- Co-expression of foreign proteins tethered to HIV-1 envelope glycoprotein on the cell surface by introducing an intervening second membrane-spanning domain (Q35164416) (← links)
- Stoichiometry of murine leukemia virus envelope protein-mediated fusion and its neutralization (Q35185954) (← links)
- Humoral responses to HIVconsv induced by heterologous vaccine modalities in rhesus macaques (Q35648017) (← links)
- Antibody mechanics on a membrane-bound HIV segment essential for GP41-targeted viral neutralization (Q35660279) (← links)
- Induction of mucosal and systemic neutralizing antibodies against human immunodeficiency virus type 1 (HIV-1) by oral immunization with bovine Papillomavirus-HIV-1 gp41 chimeric virus-like particles (Q35704086) (← links)
- Human Antibodies that Recognize Novel Immunodominant Quaternary Epitopes on the HIV-1 Env Protein (Q36076117) (← links)
- Mining the human autoantibody repertoire: isolation of potent IL17A-neutralizing monoclonal antibodies from a patient with thymoma (Q36214596) (← links)
- Structural and Thermodynamic Basis of Epitope Binding by Neutralizing and Nonneutralizing Forms of the Anti-HIV-1 Antibody 4E10. (Q36281210) (← links)
- The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5. (Q36509423) (← links)
- A glycoconjugate antigen based on the recognition motif of a broadly neutralizing human immunodeficiency virus antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the self glycans of gp120 (Q36748055) (← links)
- The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5. (Q36898696) (← links)
- Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies. (Q37002517) (← links)
- HIV-1 Neutralizing Antibodies with Limited Hypermutation from an Infant (Q37059216) (← links)
- GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium. (Q37063527) (← links)
- Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge (Q37252676) (← links)
- Evolutionary dynamics of the glycan shield of the human immunodeficiency virus envelope during natural infection and implications for exposure of the 2G12 epitope (Q37596817) (← links)
- Comparative evaluation of recombinant protein production in different biofactories: the green perspective (Q37679720) (← links)
- Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations (Q38589314) (← links)
- Human immunodeficiency virus envelope (gp120) binding to DC-SIGN and primary dendritic cells is carbohydrate dependent but does not involve 2G12 or cyanovirin binding sites: implications for structural analyses of gp120-DC-SIGN binding (Q39685547) (← links)
- Serum-free transfection of CHO cells with chemically defined transfection systems and investigation of their potential for transient and stable transfection. (Q39798607) (← links)
- Mechanistic studies of a T20-dependent human immunodeficiency virus type 1 variant (Q39982324) (← links)
- Antibody humanization by molecular dynamics simulations-in-silico guided selection of critical backmutations (Q40125548) (← links)
- Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12. (Q40204965) (← links)
- Ablation of the complementarity-determining region H3 apex of the anti-HIV-1 broadly neutralizing antibody 2F5 abrogates neutralizing capacity without affecting core epitope binding (Q40340474) (← links)
- Analysis of alterations in gene expression after amplification of recombinant genes in CHO cells (Q40818521) (← links)
- Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1 (Q41816066) (← links)
- Proteomic differences in recombinant CHO cells producing two similar antibody fragments. (Q42355436) (← links)
- The human anti-HIV antibodies 2F5, 2G12, and PG9 differ in their susceptibility to proteolytic degradation: down-regulation of endogenous serine and cysteine proteinase activities could improve antibody production in plant-based expression platforms (Q42875883) (← links)
- High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies (Q42939116) (← links)
- Evaluating the bottlenecks of recombinant IgM production in mammalian cells. (Q43147941) (← links)
- Molecular basis of unusually high neutralization resistance in tier 3 HIV-1 strain 253-11. (Q53695792) (← links)
- Functional characterization of the recombinant HIV-neutralizing monoclonal antibody 2F5 produced in maize seeds (Q57522803) (← links)